Amplify Weight Loss Drug ... (THNR)
AMEX: THNR
· Real-Time Price · USD
23.20
0.21 (0.90%)
At close: Aug 22, 2025, 2:52 PM
THNR Holdings List
As of Aug 22, 2025
The Amplify Weight Loss Drug & Treatment ETF is an equity ETF with a total of 22 individual holdings.
The top holdings are Eli Lilly and Company at 11.38%, Novo Nordisk A/S at 8.77%, Regeneron Pharmaceuticals at 7.89%, Amgen at 6.96%, and Chugai pharmaceutical co ltd at 5.83%.
22
68.45%
Equity
4.13M
22.55
0.5900%
Sector Allocation
Rank | Symbol | Name | Price | % Change | Shares | % Weight |
---|---|---|---|---|---|---|
1 | LLY | Eli Lilly and C... | 711.18 | +0.19% | 666 | 11.38% |
2 | NVO | Novo Nordisk A/... | 57.03 | +2.85% | 6.67K | 8.77% |
3 | REGN | Regeneron Pharm... | 586.90 | -1.88% | 551 | 7.89% |
4 | AMGN | Amgen Inc. | 293.84 | -0.65% | 969 | 6.96% |
5 | 4519.T | Chugai pharmace... | n/a | n/a | 5.5K | 5.83% |
6 | ABBV | AbbVie Inc. | 210.29 | +0.38% | 1.12K | 5.69% |
7 | AZN | AstraZeneca PLC | 80.94 | +0.60% | 2.88K | 5.62% |
8 | GILD | Gilead Sciences... | 114.63 | -1.3% | 1.93K | 5.54% |
9 | MRK | Merck & Co., In... | 87.22 | +1.32% | 2.64K | 5.42% |
10 | PFE | Pfizer Inc. | 25.85 | +0.41% | 8.7K | 5.35% |
11 | ROG.SW | Roche holding a... | n/a | n/a | 644 | 5.09% |
12 | 1801.HK | Innovent biolog... | n/a | n/a | 17K | 4.99% |
13 | 1093.HK | Cspc pharmaceut... | n/a | n/a | 152K | 4.88% |
14 | 4507.T | Shionogi & co l... | n/a | n/a | 10.3K | 4.49% |
15 | HIMS | Hims & Hers Hea... | 44.49 | +1.21% | 3.05K | 3.21% |
16 | ZEAL.CO | Zealand pharma ... | n/a | n/a | 1.72K | 2.65% |
17 | VKTX | Viking Therapeu... | 26.20 | +2.12% | 2.96K | 1.84% |
18 | CRNX | Crinetics Pharm... | 30.85 | +4.92% | 2.35K | 1.66% |
19 | 3933.HK | United laborato... | n/a | n/a | 26K | 1.37% |
20 | 128940.KS | Hanmi pharm co ... | n/a | n/a | 168 | 0.82% |
21 | Cash&Other | Cash & other | n/a | n/a | 12.12K | 0.29% |
22 | AGPXX | Invesco governm... | n/a | n/a | 11.66K | 0.28% |